Prilenia
Clinical trials sponsored by Prilenia, explained in plain language.
-
Hope for Huntington's: new drug aims to slow decline in major trial
Disease control Recruiting nowThis study tests whether the drug pridopidine can slow the worsening of Huntington's disease (HD) in adults. About 400 participants will take either pridopidine or a placebo twice daily for one year, then everyone can receive pridopidine for two more years. The goal is to see if …
Phase 3 • Sponsor: Prilenia • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can pridopidine slow ALS? major trial underway
Disease control Recruiting nowThis phase 3 trial is testing whether the drug pridopidine can slow the progression of amyotrophic lateral sclerosis (ALS) in 500 adults. Participants will take either pridopidine or a placebo daily for 48 weeks, followed by an open-label extension where everyone receives the dru…
Phase 3 • Sponsor: Prilenia • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC